News
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results